CEACAM5 and neoplasm: For the diagnosis and clinical monitoring of CRC, serum tumor markers (TMs) such as carcinoembryonic antigen (CEA) and the carbohydrate antigen recognized by the monoclonal antibody NS19.9 (CA 19.9) are currently used.